Amy Kearbey advises clients on health care fraud and abuse laws, coverage and reimbursement matters, and digital health strategy. She represents a broad range of health industry stakeholders, including hospital systems, medical societies, physician practice management companies, pharmaceutical and medical device companies, clinical laboratories, and data informatics companies.
Her practice includes developing compliance policies and programs, managing audits and investigations, securing OIG Advisory Opinions, and defense of False Claims Act cases. Amy also assists clients with coverage and reimbursement strategies, including payment and coverage appeals and advocacy work. Amy also has extensive experience advising on digital health strategy, with an emphasis on the complex regulatory issues presented by offerings relating to value-based payment models and innovative life sciences solutions.
Advised Fortune 500 Company regarding $2.6 Billion strategic acquisition of health analytics company
Represented a health system in the defense of a qui tam action under the False Claims Act based on alleged violations of the Stark Law and the Anti-Kickback Statute with over $1 billion in alleged damages, obtaining partial summary judgment and a negotiated settlement
Secured a favorable Advisory Opinion on behalf of a manufacturer, from the Office of Inspector General (OIG) regarding issues under the Anti-Kickback Statute and the Civil Monetary Penalties Law’s prohibition on beneficiary inducements
Serve as outside legal counsel in connection with development of a data informatics system designed to provide rapid learning in the oncology care setting
Represented a rural provider in securing a favorable settlement regarding Medicare bad debt claims in proceedings before the Provider Reimbursement Review Board